01.04
2022
AC BioScience has been awarded gold status by the EIT Health Investor Network
We have been delighted to learn that AC BioScience has been awarded gold status by the Investor Network of the European Institute of Innovation and Technology (EIT). This is a great recognition of the company's compelling science and business case", said Andreas Schläpfer, Co-founder and CEO of AC BioScience. The EIT is a network of best-in-class innovators co-funded by the European Union. Its Investor Network connects qualified companies seeking funding with the first pan-European consortium of more than 80 healthcare investors across 18 countries.
> News >
